Literature DB >> 17237035

Cancer statistics, 2007.

Ahmedin Jemal1, Rebecca Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu, Michael J Thun.   

Abstract

Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and much progress has been made in reducing mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.

Entities:  

Mesh:

Year:  2007        PMID: 17237035     DOI: 10.3322/canjclin.57.1.43

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  2000 in total

1.  A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.

Authors:  Keith C Bible; Prema P Peethambaram; Ann L Oberg; William Maples; David L Groteluschen; Matthew Boente; Jill K Burton; Leigh C Gomez Dahl; Jennifer D Tibodeau; Crescent R Isham; Jacie L Maguire; Viji Shridhar; Andrea K Kukla; Kalli J Voll; Mathew J Mauer; Alexander D Colevas; John Wright; L Austin Doyle; Charles Erlichman
Journal:  Gynecol Oncol       Date:  2012-06-01       Impact factor: 5.482

2.  Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.

Authors:  Motofumi Tanaka; Taro Okazaki; Hideo Suzuki; James L Abbruzzese; Donghui Li
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

Review 3.  Adjuvant therapy for colon cancer.

Authors:  Olivia Aranha; Al B Benson
Journal:  Curr Gastroenterol Rep       Date:  2007-10

4.  Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

5.  Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer.

Authors:  Benjamin R Kipp; Mihaela Tanasescu; Terry A Else; Sandra C Bryant; R Jeffrey Karnes; Thomas J Sebo; Kevin C Halling
Journal:  J Mol Diagn       Date:  2009-01-29       Impact factor: 5.568

6.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

7.  An EM approach to MAP solution of segmenting tissue mixture percentages with application to CT-based virtual colonoscopy.

Authors:  Su Wang; Lihong Li; Harris Cohen; Seth Mankes; John J Chen; Zhengrong Liang
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

8.  Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.

Authors:  Electra Paskett; James Herndon; Kathleen Donohue; Michelle Naughton; Stephen Grubbs; Michael Pavy; Martee Hensley; Nancy Stark; Alice Kornblith; Marisa Bittoni
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

Review 9.  Operative management of primary epithelial ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

10.  Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.

Authors:  Nathaniel S Rial; Gwendal Lazennec; Anil R Prasad; Robert S Krouse; Peter Lance; Eugene W Gerner
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.